In order to further explore the mechanism between UTX expression and EGFR signaling pathway in NSCLC, we used Gefitinib and Afatinib to treat H1975 cells and A549 cells (Li et al. 2008; Wakeling et al. 2002). The gene discussed is KDM6A; the disease is non-small cell lung carcinoma.